Early bird registration is open and closes May 2025. Register now

  • 00Days
  • 00Hrs
  • 00Mins
  • 00Secs

All about IL-6 inhibition in systemic rheumatic diseases

Synopsis:

IL-6 plays a central role in the inflammatory process of several rheumatic diseases. IL-6 inhibitors have significantly impacted the treatment of these diseases, particularly rheumatoid arthritis and other inflammatory conditions, including large vessel vasculitis and adult onset Still disease. In this workshop, we would like to deepen our understanding of IL-6 inhibition therapy in these diseases and it’s future potential through presentations by four experts.

Agenda - Thursday 4 September
Workshop chairpersons: Naoto Tamura and Yutaka Kawahito
0900-0905
Introduction
0905-0925
IL-6 inhibition in rheumatoid arthritis (including late onset RA)
Shintaro Hirata
0925-0945
IL-6 inhibition in Takayasu arteritis and giant cell arteritis
Ramnath Misra
0945-1005
IL-6 inhibition in adult onset Still disease
Yuko Kaneko
1005-1025
Future prospectives for IL-6 inhibition therapy
Masayuki Nishide
1025-1030
Closing

Share

Key dates

Registrations
Abstracts